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Various manifestations of brain involvement for patients
with virus-associated hemophagocytic syndrome have been
reported. Here, we report on the sequential magnetic resonance
(MR) findings of acute demyelination of the entire brain with
subsequent brain atrophy in a follow-up study of a 25-month-
old boy who was admitted with fever and then diagnosed with
infectious mononucleosis and EBV-associated hemophagocytic
syndrome. We also review other conditions that should be
included in the differential diagnosis of this disease.
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INTRODUCTION
Hemophagocytic syndrome is characterized by
the benign proliferation of histiocytes with the
active phagocytosis of red blood cells and tissue
infiltration of several organs by histiocytes. This
disease manifests in early infancy with fever,
hepatosplenomegaly and pancytopenia.
1-3 It can
be classified into two categories: primary or sec-
ondary form. The secondary form may develop as
an inappropriate immunologic activation secon-
dary to infection, malignancy or other immu-
nocompromised conditions.
1,4,5 Brain involvement
may develop in children with primary or secon-
dary hemophagocytic syndrome, and several
reports have described its neuroradiologic
findings.
2,6-10
We present a case of fulminent leukoencephal-
opathy in a 25-month-old boy with Epstein-Barr
virus (EBV)-associated hemophagocytic syndrome
as one of the unusual manifestations of the
disease's brain involvement.
CASE REPORT
A 25-month-old boy was referred to our hos-
pital with fever and abdominal distension for three
days. Prior to admission, he had been treated with
antibiotics for three days at an outside hospital, but
the fever had not been controlled. He was born at
full term without complication, and there was no
remarkable family history.
On admission, he was lethargic and his physical
examination revealed hepatomegaly and a skin
rash covering his whole body. His initial neurolo-
gic examination was unremarkable. Blood exami-
nations revealed anemia (hemoglobin, 10.2 g/dL),
thrombocytopenia (platelet, 110,000/ L), hyper μ -
bilirubinemia (total bilirubin, 4.1 mg/dL), and
serological studies demonstrated positive EBV
antibodies. The cerebrospinal fluid (CSF) studies
showed elevated cell counts (19 WBC/ L and 54 μ
RBC/ L) and an increased protein level (238 μ mg/
dL). A chest radiograph revealed a small right
pleural effusion. A bone-marrow biopsy was per-
formed, and hemophagocytic syndrome was diag-
nosed (Fig. 1). Karyotyping revealed no chromo-
somal abnormality.
On the 10th hospital day, an episode of gener-
alized tonic-clonic seizure occurred (this was the
first incidence), and fluid-attenuated inversion
recovery (FLAIR) magnetic resonance (MR) im-
aging of the brain showed diffuse hyperintensity
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in all of the white matter in both cerebral hemi-
spheres and in the cerebellum, including the cor-
pus callosum and internal capsule, but sparing the
subcortical U-fibers (Fig. 2). No enhancing lesions
were evident after gadolinium administration.
The patient was treated with steroids, cyclo-
sporine A, etoposide and intrathecal methotrexate
injection, and he responded to the therapy with-
out specific neurologic symptoms. A follow-up
MR examination on the 66th hospital day showed
a partial resolution of hyperintensity in the white
matter and the progressive volume loss at the
involved site (Fig. 3).
DISCUSSION
Hemophagocytic syndrome is an unusual and
fatal disorder occurring during early infancy that
is characterized by the benign proliferation of
tissue histiocytes, which is distinct from malignant
histiocytosis.
1-3 The proposed pathogenesis of this
syndrome is defective immunoregulation result-
ing in the uncontrolled proliferation of activated
histiocytes in response to a specific stimulus.
4,5
Hemophagocytic syndrome has been known to be
associated with infection (virus, bacteria, fungus
or parasitic), malignancy, drug exposure, or pro-
Fig. 1. Marrow biopsy section of the patient with EBV-associated hemophagocytic syndrome. (A) There are several
macrophages with phagocytosis of erythrocytes and lymphocytes (arrows) on hematoxylin and eosin stains (× 400). (B)
Immunohistochemical staining with panmacrophage marker CD68 shows abundant macrophages (× 400).
Fig. 2. (A-C) Axial FLAIR images of the brain show high signal intensities of the entire white matter in both hemispheres,
including the corpus callosum, internal capsule and middle cerebellar peduncle, suggesting a fulminent demyelinating
process. The preservation of white matter volume without a mass effect and a relative sparing of the subcortical U-fibers
are also noted.
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longed immunosupression, and the viruses that
have been implicated include EBV, herpes virus
and cytomegalovirus. This disease should be dis-
tinguished from familial hemophagocytic lympho-
histiocytosis, which is an autosomal recessive con-
dition that presents with similar symptoms and
pathologic features in early childhood and runs a
more severe course.
1,11-13
Histiocytic proliferation characteristically occurs
in the liver, spleen and bone marrow, although,
in severe cases, it may be seen in other organs
such as the brain, lungs and heart. The syndrome
generally begins after a short history of a nonspe-
cific viral illness, and commonly results in fever,
skin rash, hepatosplenomegaly and pancytopenia.
The disease can follow a relapsing and remitting
course, or it can progress rapidly to multi-organ
failure and death.
1-3
CNS involvement has been reported in approxi-
mately 30-50% of the cases.
6,11 A wide spectrum of
neuroradiological findings in patients with hemo-
phagocytic syndrome has been reported, and
these findings might be related to the duration or
severity of the illness. The major two radiologic
findings are: 1) diffuse leptomeningeal enhance-
ment with or without subdural fluid collection,
and 2) focal or diffuse T2 hyperintensity with or
without parenchymal volume loss of the white
matter that usually begins in the peritrigonal re-
gions.
2,6-10 These findings are well-correlated with
the neuropathologic findings, which have been
known to be: 1) diffuse infiltration of the lepto-
meninges by lymphocytes and histiocytes, 2)
dense perivascular lymphohistiocytic infiltration
in all brain regions, and 3) demyelination of the
white matter with reactive gliosis, which is
predominantly observed in the cerebellum.
2,7,8,12,14
The disease could easily be misdiagnosed in
many children because its radiographic manifes-
tations are nonspecific and overlap with various
infectious, inflammatory and neoplastic disor-
ders.
9 It is important to diagnose this condition
early and accurately during its course, as effective
treatments for hemophagcytic syndrome are now
available. Hemophagocytic syndrome is typically
managed by treatment with etoposide, steroids,
and cyclosporine A, and ultimately with an allo-
genic bone marrow transplantation from a human
leukocyte antigen-matched sibling who is unaf-
fected by the disease.
7
We present a case of infectious mononucleosis
and EBV-associated hemophagocytic syndrome
with dramatic neuroradiologic findings of conflu-
ent T2 hyperintensities affecting the entire white
matter of the cerebrum and cerebellum; this re-
sulted in severe atrophy. This finding reflected the
acute and extensive demyelination of the entire
brain, in addition to widespread tissue infiltration
of lymphocytes and erthyrophagocytic histiocytes.
Several conditions should be considered in the
differential diagnosis. Acute disseminated enceph-
alomyelopathy (ADEM) is a monophasic, post-in-
Fig. 3. Follow-up MR findings after two months with chemotherapy. (A-C) Axial FLAIR images of the brain show partial
resolution of high signal intensities of the entire white matter and the progression of atrophy at the previously-involved
site.
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fectious or post-vaccinial inflammatory disorder
characterized by multifocal white matter lesions
with bilateral and asymmetric distribution. There
is no doubt that some viruses trigger abnormal
immune responses in both conditions, but more
fulminent changes develop in the hemophagocytic
syndrome. Inherited white matter diseases such as
metachromatic leukodystrophy, Pelizaeus-
Merzbacher disease, Canavan disease or Alex-
ander disease should also be considered. The
differences between these leukodystrophies and
hemophagocytic syndrome are the previous
delayed-development patterns of the children and
a preferential involvement of the subcortical U
fibers or the contrast enhancement on imaging
findings. Various CNS complications can also
occur during treatments including bone-marrow
transplants or immunosuppressive therapy. Vas-
cular accidents including ischemia or hemorrhage,
superimposed infection, and metabolic or drug-
induced encephalopathy should also be consid-
ered for these CNS complications.
3,6
Whatever the cause, it is important for radiolo-
gists to recognize the various MR findings in the
evaluation of children with acute neurologic
symptoms associated with systemic viral infection.
Hemophagocytic syndrome-induced leukoence-
phalopathy should be also included early in the
differential diagnosis of cases with acute encepha-
lopathy showing similar clinical features. Brain
MR imagings allow physicians to assess the extent
of brain involvement in children with hemopha-
gocytic syndrome, and this may aid in monitoring
the response to treatment.
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